Canada -
English -
Health Canada
apo-abiraterone film coated tablets
apotex inc - abiraterone acetate - tablet - 500mg - abiraterone acetate 500mg - antineoplastic agents
Canada -
English -
Health Canada
pms-abiraterone tablet
pharmascience inc - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents
Canada -
English -
Health Canada
pms-abiraterone tablet
pharmascience inc - abiraterone acetate - tablet - 500mg - abiraterone acetate 500mg - antineoplastic agents
Canada -
English -
Health Canada
apo-abiraterone tablet
apotex inc - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg - antineoplastic agents
Singapore -
English -
HSA (Health Sciences Authority)
abirone abiraterone acetate tablets 250 mg
hetero singapore pte. ltd. - abiraterone acetate - tablet - abiraterone acetate 250.000 mg
Singapore -
English -
HSA (Health Sciences Authority)
arabitro abiraterone acetate tablet usp 250 mg
glenmark pharmaceuticals singapore pte. ltd. - abiraterone acetate - tablet - abiraterone acetate 250 mg
Israel -
English -
Ministry of Health
abiraterone medomie 250 mg
medomie pharma ltd, israel - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - a cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)
Israel -
English -
Ministry of Health
abiraterone s.k 250 mg
k.s.kim international (sk- pharma) ltd., israel - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - • abiraterone s.k. is cyp 17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. • abiraterone s.k. is indicated for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).
Singapore -
English -
HSA (Health Sciences Authority)
abiraterone-teva fc tablet 250 mg
teva pharmaceutical investments singapore pte. ltd. - abiraterone acetate - tablet, film coated - abiraterone acetate 250 mg
Israel -
English -
Ministry of Health
zytiga 250 mg
j-c health care ltd - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abiraterone - zytiga is a cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).